After a cancer diagnosis, patients often have many questions, not only about their treatment but also about what the ...

For the more than 300,000 women diagnosed with breast cancer each year, one of the biggest challenges is uncertainty around treatment options. Treatment isn’t one-size-fits-all and often comes with ...

In 2023, Jill Martin took a test that changed her life. She underwent genetic testing for breast cancer and learned she had a BRCA2 mutation, which increases one’s risk of developing breast and other ...

If you or a loved one are navigating the journey of prostate cancer, you know that every decision weighs heavily. You’ve likely faced surgery or initial treatments, only to encounter the fear that ...

New research highlights the impact of advanced genomic testing on reducing breast cancer survival disparities between Black and white women. By utilizing advanced gene-profiling tools, researchers ...

NGS utilization increased over time but left substantial proportions untested across metastatic breast, prostate, pancreatic, colorectal cancers and advanced NSCLC, limiting access to biomarker-driven ...

Medicare-eligible patients with advanced cancers will have access to genomic tests under a national coverage determination CMS finalized March 16. The determination covers next-generation sequencing ...